I-Deoxynojirimycin (DNJ)
Breves:
I-Deoxynojirimycin, DNJ inferius ad ut est a powerfulα, glucosidase inhibitors. Post absorptus corpore posse deactivate actio invertase, maltosum vitro, α-glucosidase et α-Lumbricus vitro reducere effusio carbohydrate concoctionem GLYCOSA, sanum sanguinem sugar campester et hypoglycemic actio melior sulfonylureas et effectus ut hypoglycemia multo minus aliis medicamentis hypoglycemic etiam bona salutem Praeterea, hoc productum est parum potentia in normalem eating.In Praeterea etiam significant DNJ antiretroviral actio, tumore metastasis ne et ea possit esse in pura maltose carrier ad summam complectitur de excelsis.
Specification:% I: 1.5%, II%, III%, V%,% X, XX% lacustris
Description: et yellowpowder
Solvent Used aqua, Fungi
Pars Collectible: folium Moro
Cas No .: 19130-96-2
Officium:
a.with observatio sanus bonum effectum in sanguinem GLYCOSA.
b. auxilium amplio cutis, cutis metabolismi et mundaret.
c. Herpesvirus hominis actio
specification:
|
Items |
DESIGNATIO |
ECFECTUS |
RATIO |
| species |
Brown pulveris |
Brown pulveris |
VISUAL |
| particula magnitudine |
Transiet per LXXX% C reticulum |
Transiet per LXXX% C reticulum |
USP33 |
| Venis |
≥ 35.0% |
36,2% |
UV |
| Siccatio in damnum |
≤5.0% |
3.1% |
USP33 |
| contentus cinis |
≤5.0% |
3.2% |
USP33 |
| Gravis Inc (PB) |
≤5ppm |
0.20ppm |
ASS |
| arsenicum |
≤2ppm |
0.12ppm |
ASS |
| Summa comitis Text |
≤1000cfu / g |
＜100cfu / g |
USP33 |
| & Yeasts Moulds |
≤100cfu / g |
＜10cfu / g |
USP33 |
| Mycobacterium |
negans |
negans |
USP33 |
| E.coli |
negans |
negans |
USP33 |
| Conclusio est secundum speciem. Repono: Cool & siccum locum .Keep a fortis calor et lux. Fasciae vita: Min. XXIV menses, cum bene condita. Stipare, 25kg / tympanum |
|||
| per rechecked：Liu Zeng | approbata a SRC：li Shuliang | ||
